GL · Globe Life Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.99B | $5.78B | $5.45B | $5.21B | $5.11B | $4.74B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | $1.26B | $982.86M | $853.07M | $901.05M |
| R&D | - | - | - | - | - | - |
| SG&A | - | - | $302.06M | $307.52M | $282.03M | $254.93M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $30.00M | $27.00M | $21.00M | $21.00M | $20.00M | $17.00M |
| Operating Income | $1.44B | $1.33B | $1.27B | $990.67M | $864.97M | $905.36M |
| Interest Expense | $141.22M | $127.09M | $102.32M | $90.39M | $83.49M | $86.70M |
| Income Tax | $274.74M | $255.88M | $223.51M | $166.61M | $167.43M | $164.91M |
| Net Income | $1.16B | $1.07B | $970.75M | $739.70M | $744.96M | $731.77M |
| EPS - Basic | $14.27 | $11.99 | $10.21 | $7.55 | $7.30 | $6.90 |
| EPS - Diluted | $14.07 | $11.94 | $10.07 | $7.47 | $7.22 | $6.82 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $144.70M | $165.32M | $103.16M | $92.56M | $92.16M | $94.85M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $30.81B | $29.08B | $28.05B | $25.54B | $29.77B | $29.05B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | $2.32B | $2.32B | $1.63B | $1.63B | $1.55B | $1.67B |
| Total Liabilities | $24.84B | $23.77B | $23.56B | $20.64B | $21.13B | $20.28B |
| Stockholders' Equity | $5.97B | $5.31B | $4.49B | $4.90B | $8.64B | $8.77B |
| Retained Earnings | $8.55B | $8.00B | $7.48B | $6.47B | $6.18B | $5.87B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.40B | $1.40B | $1.48B | $1.42B | $1.44B | $1.48B |
| Investing Cash Flow | ($643.62M) | ($641.52M) | ($926.15M) | ($943.01M) | ($913.37M) | ($1.18B) |
| Financing Cash Flow | ($768.05M) | ($715.84M) | ($541.49M) | ($492.45M) | ($523.60M) | ($274.06M) |
| CapEx | $142.48M | $71.05M | $49.55M | $27.93M | $38.24M | $41.76M |
| Free Cash Flow | $1.25B | $1.33B | $1.43B | $1.39B | $1.40B | $1.43B |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | 23.1% | 18.8% | 16.7% | 19.0% |
| Operating margin | 24.0% | 23.0% | 23.2% | 19.0% | 16.9% | 19.1% |
| EBITDA margin | 24.5% | 23.4% | 23.6% | 19.4% | 17.3% | 19.5% |
| Net margin | 19.4% | 18.5% | 17.8% | 14.2% | 14.6% | 15.4% |
| Free cash flow margin | 20.9% | 23.0% | 26.3% | 26.7% | 27.4% | 30.3% |
| FCF / Net income | 1.08 | 1.24 | 1.48 | 1.88 | 1.88 | 1.96 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | 5.5% | 5.9% | 5.5% | 5.4% |
| Effective tax rate | 19.1% | 19.3% | 18.7% | 18.4% | 18.4% | 18.4% |
| Return on assets | 3.8% | 3.7% | 3.5% | 2.9% | 2.5% | 2.5% |
| Return on equity | 19.4% | 20.2% | 21.6% | 15.1% | 8.6% | 8.3% |
| Return on invested capital | 14.0% | 14.0% | 16.8% | 12.4% | 6.9% | 7.1% |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | 0.39 | 0.44 | 0.36 | 0.33 | 0.18 | 0.19 |
| Debt / Assets | 0.08 | 0.08 | 0.06 | 0.06 | 0.05 | 0.06 |
| Debt / EBITDA | 1.58 | 1.72 | 1.27 | 1.61 | 1.75 | 1.81 |
| Interest coverage | 10.2x | 10.4x | 12.4x | 11.0x | 10.4x | 10.4x |
| Equity multiplier | 5.16 | 5.48 | 6.25 | 5.22 | 3.44 | 3.31 |
| Liabilities / Assets | 0.81 | 0.82 | 0.84 | 0.81 | 0.71 | 0.70 |
| Efficiency | ||||||
| Asset turnover | 0.19 | 0.20 | 0.19 | 0.20 | 0.17 | 0.16 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 9.9x | 9.3x | 12.1x | 16.1x | 13.0x | 13.9x |
| P / B | 1.9x | 1.9x | 2.6x | 2.4x | 1.1x | 1.2x |
| P / S | 1.9x | 1.7x | 2.2x | 2.3x | 1.9x | 2.1x |
| EV / EBITDA | 9.4x | 9.0x | 10.3x | 13.3x | 12.6x | 12.7x |
| Growth | ||||||
| Revenue growth (YoY) | 3.7% | 6.1% | 4.5% | 2.0% | 7.9% | 4.6% |
| Revenue CAGR (3y) | 4.8% | 4.2% | 4.8% | 4.8% | 5.9% | 4.5% |
| Revenue CAGR (5y) | 4.8% | 5.0% | 4.8% | 4.6% | 5.4% | 4.7% |
| Gross profit growth (YoY) | - | - | 28.2% | 15.2% | -5.3% | -1.1% |
| Operating income growth (YoY) | 8.2% | 4.9% | 27.7% | 14.5% | -4.5% | -1.6% |
| Net income growth (YoY) | 8.4% | 10.3% | 31.2% | -0.7% | 1.8% | -3.8% |
| EPS growth (YoY) | 17.8% | 18.6% | 34.8% | 3.5% | 5.9% | -0.1% |
| EPS CAGR (3y) | 23.5% | 18.3% | 13.9% | 3.0% | 5.8% | -17.7% |
| EPS CAGR (5y) | 15.6% | 11.8% | 10.6% | -9.4% | 10.0% | 10.4% |
| FCF growth (YoY) | -5.8% | -7.1% | 2.8% | -0.4% | -2.5% | 8.6% |
| FCF CAGR (5y) | -2.7% | 0.1% | 3.1% | -0.2% | 0.4% | 11.6% |
| Book value growth (YoY) | 12.6% | 18.2% | -8.4% | -43.4% | -1.5% | 20.2% |
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
6/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- -Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Life Insurance
Comparing GLOBE LIFE INC. against the 5 most active filers in the same SIC group.
Dividends
$1.14/share trailing 12 months · +15.2% YoY
| Ex-date | Per share |
|---|---|
| Apr 2, 2026 | $0.3300 |
| Jan 5, 2026 | $0.2700 |
| Oct 3, 2025 | $0.2700 |
| Jul 3, 2025 | $0.2700 |
| Apr 3, 2025 | $0.2700 |
| Jan 6, 2025 | $0.2400 |
| Oct 4, 2024 | $0.2400 |
| Jul 5, 2024 | $0.2400 |
| Apr 4, 2024 | $0.2400 |
| Jan 4, 2024 | $0.2250 |
| Oct 5, 2023 | $0.2250 |
| Jul 3, 2023 | $0.2250 |
| Mar 31, 2023 | $0.2250 |
| Jan 5, 2023 | $0.2080 |
| Oct 6, 2022 | $0.2080 |
| Jul 1, 2022 | $0.2080 |
| Apr 1, 2022 | $0.2080 |
| Jan 6, 2022 | $0.1980 |
| Oct 1, 2021 | $0.1980 |
| Jul 1, 2021 | $0.1980 |
| Apr 1, 2021 | $0.1980 |
| Jan 7, 2021 | $0.1880 |
| Oct 2, 2020 | $0.1880 |
| Jul 2, 2020 | $0.1880 |